Home › Triple-Negative Breast Cancer › Nevada › Reno
Triple-Negative Breast Cancer clinical trials in Reno, NV
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Reno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
RecruitingPhase 3
- Renown Regional Medical Center ( Site 0005), Reno
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Renown Regional Medical Center ( Site 0041), Reno
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RecruitingObservational study
- Cancer Care Specialist of Reno, Reno
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Reno
- Non-Small Cell Lung Cancer16 studies
- Breast Cancer13 studies
- Lung Cancer9 studies
- Macular Degeneration8 studies
- Geographic Atrophy8 studies
- Ovarian Cancer7 studies
- Cancer (all types)7 studies
- Acute Myeloid Leukemia5 studies
- Pancreatic Cancer5 studies
- Metastatic Cancer5 studies
- Colon Cancer5 studies
- Colorectal Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.